Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Net Current Assets

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Net Current Assets (Including Current Investments) ₹211 Cr₹168 Cr₹69 Cr₹62 Cr₹28 Cr

What is the latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Net Current Assets ratio of SYNCOM FORMULATIONS (INDIA) is ₹211 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹211 Cr
Mar2024₹168 Cr
Mar2023₹69 Cr
Mar2022₹62 Cr
Mar2017₹28 Cr

How is Net Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?

Years Net Current Assets % Change
Mar2025 ₹211 Cr
25.20
Mar2024 ₹168 Cr
145.53
Mar2023 ₹69 Cr
11.35
Mar2022 ₹62 Cr
122.16
Mar2017 ₹28 Cr -

Compare Net Current Assets of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,396.8 Cr -3.9% -7.5% -31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,753.0 Cr -0.2% 6.1% 0.3% Stock Analytics
DIVIS LABORATORIES ₹167,998.0 Cr -1.4% -4.9% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,186.0 Cr 0.8% 5% 12.9% Stock Analytics
CIPLA ₹120,960.0 Cr -1.3% -0.5% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,759.0 Cr -0.7% 5.1% 4.9% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-3.9%

-7.5%

-31.4%

SENSEX

-0.6%

2.2%

5.3%


You may also like the below Video Courses